In countries with organized screening programs, regular breast cancer screening has been a crucial tool in the clinician toolkit, decreasing breast cancer mortality rates by up to 40%.



Jesse Ehrenfeld, MD, MPh, FAMIA, FASA, FCPP, president of the American Medical Association (AMA), addressed the topic of broader digital health trends during the recent 2023 AIMed Global Summit, highlighting some of the ways the AMA is working to ensure physicians are actively and deeply involved in the development of new technologies in medicine.


September 21, 2023 — Declines in cardiovascular procedure volumes observed early in the COVID-19 pandemic greatly recovered in 2021 in the U.S.

September 21, 2023 — Imaging Biometrics, LLC announced the results of a study that validates IB Neuro’s processing of reduced-dose 

September 21, 2023 — Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT mаchines, using the perovskite-based photoconverters.


The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO.



An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of progress on proton therapy worldwide. For its part, RaySearch Laboratories AB, a Swedish medical technology company which develops software solutions for cancer treatment, has generated attention for multiple newsworthy developments.


September 20, 2023 — aycan, a recognized leader in medical imaging, announced today a new solution for reviewing DICOM images, the aycan referral physician and patient portal. Powered by a MedDream DICOM Viewer, this solution offers basic manipulation and measurement tools for quick and easy review of medical images. 


Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ability of radiology healthcare professionals to identify excess exposure to radiation in patients, which could result in both short- and long-term health effects. Understanding the effects of radiation on patients’ health and implementing effective radiation dose management through the adoption of innovative technologies can improve imaging practices and overall patient safety.



Handheld ultrasound has not yet reached mainstream adoption, but the market is still forecast to reach over $500 million by 2026. Signify Research’s newly-published Handheld Ultrasound Deep Dive Report 2022 shows the market revenues are estimated to have grown by approximately 30% in 2021, driven by strong growth in the U.S., the biggest market for handheld ultrasound.


Subscribe Now